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THE ROLE OF INTEGRINS ON MEGAKARYOCYTE 
DEVELOPMENT AND FUNCTION 
XIAOSHENG YANG 
ABSTRACT 
Integrins are cell surface receptors mainly involved with cell-cell adhesion and cell 
adhesion to extracellular matrix (ECM) proteins. Integrin signaling participates in many 
cellular pathways and has multiple effects on cell behavior. The role of integrins on 
megakaryocytes (MKs) has been extensively studied, and integrins have been proven to be 
vital in regulating MK development and functions. MKs are large platelet-producing cells 
primarily residing in the bone marrow (BM). The interactions between MK and ECM 
proteins in the BM via integrins are thought to play an important role in maintaining normal 
thrombopoiesis, and deregulation of integrin signaling may lead to impaired MK 
maturation, MK migration, and proplatelet formation. Integrins also take part in the cell-
cell adhesion of MK to other cells in the BM, such as osteoblasts and fibroblasts. MK 
adhesion is proved to stimulate the expansion of fibroblasts and osteoblasts, which may 
have strong implications for treating bone marrow fibrosis (BMF) and osteoporosis. In this 
review, we introduce different types of integrins expressed on MK and discuss their roles 
during MK differentiation and maturation from hematopoietic stem cells (HSCs) as well 
as their functions during thrombopoiesis. We also focus on surveying the interactions of 
 
vi 
MK with other BM cells via integrin signaling and examining the functions of MK 
integrins in regulating BM homeostasis. Finally, we explain diseases caused by defects 
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INTRODUCTION: INTEGRINS ON MEGAKARYOCYTES 
  
Integrins are heterodimers consisting of two subunits called α and β, and a total of 18 
α and 8 β subunits have been identified on mammalian cells, the combination of which 
forms 24 distinct types each serving a necessary function evidenced by mice knockout 
studies (Hynes 2002). Integrins are transmembrane cell surface receptors with extracellular 
domains interacting with ECM ligands such as collagen, fibronectin, vitronectin, and 
laminin as well as cytoplasmic domains connecting to the actin cytoskeleton via an 
adhesion complex consisting of multiple other factors, and the ECM-integrin-actin 
cytoskeleton axis serves as the mechanical signal which can activate a variety of 
downstream signaling pathways regulating cell survival, cell proliferation, cell motility, 
transcriptional control and cytoskeletal organization (Hynes 1992, Zamir and Geiger 2001, 
Hynes 2002). 
Integrins expressed on MKs as well as their roles in regulating MK development and 
function has been well characterized. We will provide an overview of all types of integrins 
expressed on MKs, their respective ECM ligands as well as their effects on MK functions 





The β1 integrins 
 
The β1 integrins, also called the Very Late Antigens (VLA), refer to a group of 
integrins that share a common β1 subunit. On mature MKs, α2β1 (VLA-2), α3β1 (VLA-
3), α5β1 (VLA-5), and α6β1 (VLA-6) integrins are being expressed. Α4β1 (VLA-4) 
integrins are proved to only exist on small immature MKs (Mossuz, Schweitzer et al. 1997).  
α2β1 integrin adheres primarily to collagen and laminin, and it is considered to be 
crucial for actin stress fiber formation in MKs, which mediates MK spreading and 
migration (Sabri, Jandrot-Perrus et al. 2004). However, the function of α2β1 integrin on 
thrombopoiesis is complex and still under debate, which will be explained in later sections. 
α3β1 integrin adhere primarily to fibronectin, and in contrast to the homogenous 
staining pattern on MKs exhibited by other integrins, α3β1 integrin exhibited a 
heterogeneous focal distribution in MKs (Schmitz, Thiele et al. 1998). Although not being 
reported in regulating MK maturation or thrombopoiesis, α3β1 has been proved to play 
central roles in MK induced osteoblast and fibroblast proliferation (Schmitz, Thiele et al. 
1998, Lemieux, Horowitz et al. 2010). 
Both α4β1 and α5β1 integrins bind to fibronectin, but at different sites, with α4β1 
binding to the spliced V region and α5β1 to the RGD (Ar tripeptide motif (Guan and Hynes 
1990, Hemler 1990). Α4β1 and α5β1 integrins are shown to be involved with MK growth 
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and proplatelet formation. (Fox and Kaushansky 2005, Matsunaga, Fukai et al. 2012, 
Matsuura, Thompson et al. 2020). 
α6β1 integrin is proven to adhere to laminin (Sonnenberg, Modderman et al. 1988), 
but the specific effects of α6β1 integrin on MK functions are not well documented, only 





αVβ3 integrin mainly adheres to vitronectin, but it can also bind to fibrinogen, 
fibronectin, thrombospondin, and von Willebrand factor (vWF) (Leven and Tablin 1992, 
Handagama, Bainton et al. 1993, Gao, Lindberg et al. 1996, Zhang, Varas et al. 2007). The 
presence of αβ3 integrin was first reported on guinea pig MKs and shown to support 
proplatelet formation (Leven and Tablin 1992). ΑVβ3 integrin is also considered to be 
involved with endocytosis of fibrinogen, an essential factor for blood clot formation, into 







αIIbβ3 integrin was first identified as a platelet glycoprotein, named as glycoprotein 
GPIIb/IIIa complex. αIIbβ3 integrin is required for platelet aggregation, and found to be a 
MK/platelet lineage-specific integrin (Bennett 2005). αIIbβ3 mainly serves as a receptor 
for fibrinogen, but it can also bind to the RGD motif-containing ligands such as fibronectin, 
vWF, and thrombospondin (Perutelli and Mori 1992). αIIbβ3 plays multiple important roles 
in regulating MK function such as endocytosis of fibrinogen, proplatelet formation, and 




Table 1: Integrins expressed on MKs, their major ECM ligands, as well as their regulatory 
functions in MKs are summarized here 
Integrin 
Type ECM ligands Regulatory functions in MKs 
𝛼"𝛽$ Collagen, laminin 
MK spreading, migration, and proplatelet 
formation 
𝛼%𝛽$ Fibronectin 
MK induced osteoblast and fibroblast 
proliferation 
𝛼&𝛽$ Fibronectin 
Only exist on MK progenitors and 
immature MKs, MK growth 
𝛼'𝛽$ Fibronectin MK growth, proplatelet formation 
𝛼(𝛽$ Laminin Proplatelet formation 
𝛼))*𝛽% Fibrinogen, fibronectin, vWF  
Endocytosis of fibrinogen, MK spreading, 
migration, and proplatelet formation 







THE EXPRESSION OF INTEGRINS DURING MEGAKARYOPOIESIS 
 
Megakaryopoiesis, the process of HSCs differentiating into mature MKs, is complex 
and involves multiple progenitors. The classical model of megakaryopoiesis starts from 
HSCs develop into two branches of common myeloid progenitors (CMPs) and common 
lymphoid progenitors (CLPs). The CMPs then give rise to megakaryocyte-erythrocyte 
progenitors (MEPs), which in turn give rise to unipotent MK precursors (Debili, 
Coulombel et al. 1996, Akashi, Traver et al. 2000). Adolfsson. et al. supplemented the 
classical model by showing that there is certain subpopulation within HSCs that have a 
higher capacity to form MKs. The study demonstrated that within the HSC compartment 
(Lin-Sca-1+c-kit+), a subset of CD34+ and FMS-like tyrosine kinase3 negative (Flt3-) 
cells have high megakaryocytic potential, and 57% of Flt3- cells produced megakaryocytes 
in vitro under thrombopoietin (TPO) treatment whereas the CD34+Flt3+ subset only 
exhibit very limited megakaryocyte differentiation (Adolfsson, Mansson et al. 2005).  
Besides the CD34+ fraction of the HSC, a recent study using transposon tagging has 
demonstrated that long-term HSC (CD34-Flt-) can directly generate unipotent MK 
precursors (without other intermediate progenitors) in vivo during unperturbed 
hematopoiesis, and a fraction of long-term HSC expressing CD41 (αIIb integrin) is primed 
for MK lineage differentiation(Rodriguez-Fraticelli, Wolock et al. 2018).  
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Early research to investigate integrin expression during megakaryopoiesis was 
performed on K562 cell line derived from human chronic myeloid leukemia cells. K562 
cells can be induced to have megakaryocytic differentiation under phorbol 12,13-dibutyrate 
treatment, and the expression of integrin αIIbβ3 and α2β1 was found to be highly increased 
in phorbol treated K562 cells (Lozzio and Lozzio 1977, Burger, Zutter et al. 1992). Later 
studies to examine integrin expression during MK differentiation from purified CD34+ 
progenitor cells were shown to be consistent with the previous results. α2β1 integrin is 
proved to be expressed exclusively on mature polyploid MKs among other bone marrow 
cells, and the MK lineage-specific integrin, αIIbβ3 integrin, is expressed early in MK 
progenitors, and keeps increasing as MKs mature and grow larger in size (Mossuz, 
Schweitzer et al. 1997, Poujol, Nurden et al. 1997, Molla, Mossuz et al. 1999).  
α4β1 integrin is found to be expressed on MK progenitors and small immatures MKs, 
and the presence of α4β1 integrin becomes absent on large mature MKs. This is opposite 
to the α5β1 integrin which is highly expressed on large mature MKs instead of the 
immature ones (Molla, Mossuz et al. 1999). The expression of the laminin receptor, 
α6β1integrin, appears early on immature MKs and remains a relatively constant expression 
level throughout MK maturation (Mossuz, Schweitzer et al. 1997). The observations that 
early immature MKs mainly adhere to fibronectin and laminin but not to collagen and the 
capacity to bind collagen to appear only in mature MKs are consistent with the expression 
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levels of those β1 integrins during MK maturation (Molla, Mossuz et al. 1999).  
As for the vitronectin receptor, αvβ3 integrin expression is detected in early MKs; 
however, as MK grows in size and becomes more mature, αvβ3 expression decreases 
(Poujol, Nurden et al. 1997). From these studies, it is clear that integrin expression is highly 
regulated during MK differentiation and maturation from HSC, the expressional profile of 
integrins from MK progenitors to mature MKs are significantly different.  
Blocking studies using antibodies against integrins during megakaryopoiesis can 
provide valuable insights to assess how integrins affect MK differentiation and 
development. Using human cord blood CD34+ cells, Han. et al showed that blocking of β1 
integrins significantly reduced the generation of MK progenitors assessed by CFU-MK 
assay (Han, Guo et al. 2004). Consistent results were also obtained by Fox. et al when they 
found an integrin pan-blockade molecule, kistrin, abolished in vitro TPO-induced 
megakaryopoiesis, but a more specific disintegrin against α5β1 integrin, EMF10, 
surprisingly did not affect megakaryopoiesis. However, a neutralizing anti-α4β1 
monoclonal antibody was shown to block megakaryopoiesis, and supplementing the 
medium with an α4β1 integrin ligand, the H296 fragment of fibronectin, stimulated MK 
growth at all concentrations of TPO (Fox and Kaushansky 2005).  
This result is in agreement with another finding in the study of Han and colleagues in 
which they also found that the addition of fibronectin stimulated expression of CD41d (α4 
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subunit) and enhanced the generation of MK progenitors (Han, Guo et al. 2004). However, 
regarding the function of α5β1 integrin during megakaryopoiesis, a recent study had a 
controversial result showing a neutralizing antibody to α5 subunit caused a reduction in 
megakaryocyte cultured from murine CD34+ cells (Matsuura, Thompson et al. 2020).  
The functions of β3 integrins were also proved to be essential during megakaryopoiesis. 
Anti-β3 antibodies drastically inhibited MK proliferation and the formation of CFU-MK 




MK INTEGRINS REGULATE THROMBOPOIESIS 
  
Thrombopoiesis, the production of platelets, is the most important function carried out 
by MKs. Thrombopoiesis is a multistep process involving MK spreading and adhesion, 
MK migration, proplatelet formation, and proplatelet release (Patel, Hartwig et al. 2005).  
Under normal conditions, thrombopoiesis starts from MKs residing in the BM osteoblastic 
niche adhering to ECM proteins via integrins, then spreading and migrating along with the 
ECM matrix to the vascular niche containing BM sinusoids. MKs then start to form 
multiple long cytoplasmic processes called proplatelets extending into sinusoids, and blood 
flowing through the sinusoids provides a shear force that can tear off proplatelets into the 
systemic circulation (Junt, Schulze et al. 2007). Further fragmentation of proplatelets 
generate platelets, and the lung is proven to be a major site for this process where half of 
the platelets for steady-state maintenance are generated. MKs sometimes can also exit BM 
space and enter systemic circulation, and the generation of platelets from those MKs are 
also believed to happen in the lung (Lefrancais, Ortiz-Munoz et al. 2017). MK integrins 
are considered to play central roles in MK adhesion, MK spreading, MK migration as well 
as proplatelet formation, and thus essential for regulating thrombopoiesis. The specific 




MK ADHESION, SPREADING, AND MIGRATION 
  
Adhesion, spreading, and migration are interconnected processes that happen in 
sequential order. Both intracellular and extracellular signals can cause integrins to be 
activated, cluster together, and bind to ECM ligands, thereby forming focal adhesion 
complex which connects to cytoskeleton actin filaments via other linker proteins such as 
vinculin and talin (Giancotti 2003). Cell spreading is characterized by the observations that 
upon adhesion the ECM ligand, cells become flattened out and exhibit protrusion structures 
called filopodia and lamellipodia, which are formed by polymerized actin stress fiber 
assembled by the focal adhesion complex (Fardin, Rossier et al. 2010). The assembly of 
actin stress fibers and the formation of cell protrusions has been proved to play central roles 
in cell motility and migration along with the ECM (Ridley, Schwartz et al. 2003). 
Activation of integrins on MKs, adhesion to ECM ligands, as well as integrin effects on 
MK spreading and migration has been extensively studied and proved to be involved with 
numerous factors and cellular pathways. 
Early in vitro adhesion assay on MKs found that MKs from day 7 culture of CD34+ 
cells only showed affinity to fibronectin. Anti-β3 and anti-αIIbβ3 antibodies do not affect 
reducing the affinity to fibronectin whereas anti-α5 subunit antibody reduced the affinity 
by 40% and anti-β1 antibody as well as RGD sequence abolished adhesion to fibronectin 
(Berthier, Jacquier-Sarlin et al. 1998). The results suggest α2β1, α6β1, as well as αvβ3 
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integrins are in an inactivated state by default, unable to bind their corresponding ECM 
ligands: collagen, laminin, and vitronectin. αIIbβ3 integrin did not contribute to adhesion 
to fibronectin as suggested by the abolishing effect of anti-β1 antibodies; however, the 
reason that anti-α5 subunit antibody only diminished adhesion by 40% remain to be 
elucidated. A possible explanation is the presence of other adhesion molecules besides 
integrins. On the other hand, αIIbβ3 can be activated under the stimulation of TPO and 
gain the ability to bind both fibronectin and fibrinogen in another study (Zauli, Bassini et 
al. 1997).  
Later results are shown by Schick el. al. are consistent with the two previous studies 
which summarize the role of α5β1 and αIIbβ3 integrins in MK adhesion. Schick et. al found 
that resting MKs could not bind fibrinogen, and EMF-10, a disintegrin highly specific for 
α5β1 (Marcinkiewicz, Calvete et al. 1999), blocked adhesion to fibronectin whereas 
antibodies against αIIbβ3, αvβ3, α4β1 did not. Once MKs were activated by thrombin, they 
became able to adhere to fibrinogen primarily via αIIbβ3 integrin, and both α5β1 and 
αIIbβ3 integrins started to mediate fibronectin adhesion as evidenced by the requirement 
for inhibitors of both integrins to abolish fibronectin-binding (Schick, Wojenski et al. 1998).  
αIIbβ3 integrin seemed to play a major role in MK spreading and migration. An early 
study by Leven et al. showed that MK spreading was found to be stimulated by thrombin, 
but an antibody to αIIbβ3 inhibited MK spreading on guinea pig MKs (Leven 1995). 
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Mazharian et al. showed that MK spreading and migration on fibronectin was abolished by 
an αIIbβ3 integrin antagonist, lotrafiban (Mazharian, Thomas et al. 2010). Although the 
collagen receptor, α2β1 integrin are shown to be spread on collagen and form actin stress 
fiber [Sabri, 2004], MKs were not observed to migrate on a collagen matrix (Mazharian, 
Thomas et al. 2010). The effect of other MK integrins on MK spreading and migration are 
not well documented, only with one study showing that anti-αvβ3 antibodies inhibit MK 
migration via suppressing Protein kinase B (AKT) activation (Zeng, Chen et al. 2018). 
 Extensive research has been focused on the αIIbβ3 integrin, and αIIbβ3 integrin has been 
proved to mediate MK adhesion, spreading, as well as migration via numerous factors and 
pathways. Besides TPO and thrombin, typical platelet agonists, ADP, and epinephrine, as 
well as thrombin receptor agonists both increased αIIbβ3 adhesion to fibrinogen (Shiraga, 
Ritchie et al. 1999). SDF-1α, an agonist to α-chemokine receptor CXCR4, also stimulated 
fibrinogen binding (Wang, Liu et al. 1998). NF-E2, an important transcriptional factor for 
MK maturation and platelet production (Shivdasani 1996), has also been proved to regulate 
αIIbβ3 integrin activation. In NF-E2 gene knockout mice, despite normal expression of 
αIIbβ3, fibrinogen binding capacity was lost (Shiraga, Ritchie et al. 1999).  
Adhesion to fibrinogen has also been proved to be mediated by the Rap signaling 
pathway. The increased expression of CalDAG-GEFI, a Rap1 exchange factor, activated 
Rap1b and enhanced MK adhesion to fibrinogen through inside-out signaling to αIIbβ3 
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integrin (Eto, Murphy et al. 2002). Inhibition of Rasa3, a GTPase activating protein 
targeting Rap1, activated Rap1 and resulted in a constitutive binding of fibrinogen to 
αIIbβ3 integrin (Molina-Ortiz, Polizzi et al. 2014). 
The cytoplasmic tail of αIIb subunit also serves as a regulatory domain for αIIbβ3 
activation. Talin, a factor involved in focal adhesion complex, has been proved to activate 
αIIbβ3 integrin by interacting with the cytoplasmic tail of αIIb subunit (Petrich, Marchese 
et al. 2007) whereas calcium and integrin-binding protein 1 (CIB1) binds to the same site 
and serves as a competitive inhibitor that blocks αIIbβ3 integrin activation (Yuan, Leisner 
et al. 2006). 
The αIIbβ3 pathway is also regulated by the WAVE/Abi pathway associated with the 
Wiskott-Aldrich syndrome, MKs in WAVE2 knock-out mice exhibit problems spreading 
on fibrinogen due to defects in the formation of lamellipodia (Eto, Nishikii et al. 2007). 
αIIbβ3 integrin is also proved to stimulate MK motility and migration via SFKs (Src Family 
Kinase)-Syk-PLCγ2 signaling. αIIbβ3 signaling is proved to phosphorylate Src kinases, 
Syk, as well as PLCγ2, and inhibitors against SFKs and Syk kinase block MK spreading 
and migration. MK spreading and migration are also inhibited in MKs derived from mice 





   
As MKs mature, they grow in cytoplasmic size and nuclear ploidy via a process called 
endomitosis, a mitosis event with a failure in late cytokinesis and a defect in karyokinesis, 
leading to a giant cell with an average ploidy of 16N (Mazzi, Lordier et al. 2018). As MK 
cytoplasm expands, an intracellular interconnected membranous network consisting of 
cisternae and tubules is formed. Referred as demarcation membrane system (DMS), this 
network serves as membrane reservoir for proplatelets formation. Dense granules present 
in platelets such as α-granule are also formed as MKs mature, clotting factors such as vWF 
and fibrinogen are packaged into these granules before proplatelet formation (Heijnen, 
Debili et al. 1998).  
 Proplatelet formation starts from a single site on MKs where a broad pseudopodium 
forms and continues to elongate forming a long cytoplasmic process with bulbous ends. 
Additional proplatelets are generated at or near the original site (Mazzi, Lordier et al. 2018). 
Microtubule bundles are visualized to fill proplatelet using GFP-tagged β1-tubulin 
(Schulze, Korpal et al. 2004), and proplatelet elongation is believed to be caused by the 
microtubule sliding mechanism associated with the microtubule molecular motor protein, 
dynein (Patel, Richardson et al. 2005). Branching of proplatelets is also observed and 
considered to be associated with actin filament aggregation regulated by protein kinase C 
(PKC) and integrin signaling pathways (Italiano, Lecine et al. 1999, Rojnuckarin and 
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Kaushansky 2001). In vitro, proplatelet release from MK cell bodies is aided by fluid shear 
force, and proplatelets can further fragment and generate platelets (Junt, Schulze et al. 
2007). 
 The influence of MK integrins on regulating proplatelet formation has been investigated 
extensively. It turns out that the effects on proplatelet formation varied by the type of 





Early research to investigate the effect of αvβ3 integrin on proplatelet formation was 
done on guinea pig MKs. Leven et al. showed that LM609, an antibody specific for αbβ3 
integrin, blocked proplatelet formation whereas antibodies to β1, α5, α6 subunits as well 
as a fibrinogen gamma chain peptide designed to bind αIIbβ3 peptide had no effect on 
proplatelet formation. They have also shown that adding vitronectin to a non-serum MK 
culture stimulated proplatelet formation to a level equivalent to that of a serum MK culture, 
suggesting vitronectin/αvβ3 signaling pathway is the major player in proplatelet formation 
(Leven and Tablin 1992). However, in another study performed on human MKs, antibody 
to αvβ3 only slightly reduced MK colony size and had no significant effect on proplatelet 
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formation (Takahashi, Sekine et al. 1999).  
Those contradictory results may be partly due to the difference in expression levels of 
αVβ3 integrin. αVβ3 integrin has been proved to be present more in α-granule and less on 
the plasma membrane in mature human MKs, and the cellular expression of αVβ3 
decreases as human MKs mature (Poujol, Nurden et al. 1997). On the other hand, guinea 
pig MKs express much more αVβ3 integrin compared to human MKs (Leven 1995). These 
findings suggest that the role of αVβ3 integrin on proplatelet formation is not conserved 




   
Sabri et al. found that compared to PLL substrate, proplatelet formation were reduced 
by 3-fold when MKs were attached to collagen I coated slides via α2β1integrin [Sabri, 
2004]. The inhibition of proplatelet formation via α2β1 integrin is considered to be 
involved with the Rho/ROCK pathway as evidenced by the restoration of proplatelet 
formation by inhibitors of the Rho/ROCK pathway. The downstream effects of the 
Rho/Rock pathway are shown to involve phosphorylation of myosin light chain (MLC), 
which stimulates action-dependent myosin motor activity considered to mediate MK 
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spreading and migration but reduce proplatelet formation. Collagen adhesion is thus 
believed to serve in vivo functions to assist the migration of MKs and prevent premature 
proplatelet formation while the MKs are still in the osteoblastic niche (Chen, Naveiras et 
al. 2007). The Rho/Rock pathway is also associated with microtubule assembly and 
stabilization, which play central roles in proplatelet elongation (Cook, Nagasaki et al. 1998). 
Consistent results are obtained in an in vitro adhesion assay by Larson et al. who report 
that MKs exhibited the highest proportion of proplatelet formation when plated on 
fibrinogen whereas collagen only stimulated a high level of adhesion but was unable to 
support proplatelet formation (Larson and Watson 2006).  
 The mechanical tensile strength exerted by collagen has been suggested to regulate α2β1 
integrin signaling. In one study, collagen was modified to be less stiff via N-acetylation, 
and proplatelet formation was not inhibited when MKs were attached to the modified 
collagen (Malara, Gruppi et al. 2011). 
 The in vivo effects of α2β1 integrin on proplatelet formation and platelet production 
seem to be controversial. Systematic knockout of α2 subunit in mice resulted no difference 
in platelet number, platelet volume, MK count, MK maturation, MK localization within the 
BM and MK association to sinusoids compared to wildtype mice. MKs were only observed 
to have reduced adhesion to collagen type I filaments at sinusoids compared to wildtype 
mice (Semeniak, Faber et al. 2019). On the other hand, using a Cre/α2β1 model in which 
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gene encoding for α2 subunit is conditionally knocked out only for MK lineages, 
researchers found that although those mice have normal platelet counts and functions, the 
mean platelet volume is reduced (Habart, Cheli et al. 2013). The reduction in platelet size 
may be partly explained by the formation of proplatelets when MKs are underdeveloped 
and inadequate in size, suggesting α2β1 integrin may play a role in stimulating the 
maturation of MKs before MKs migrate to the vascular niche. However, the normality 
observed in systematic knockout mice suggests α2β1 integrin signaling is not essential for 
proplatelet formation and platelet production, and there may be other compensatory 
mechanisms during early development that can replace α2β1 integrin functions while those 
compensatory mechanisms are lost or can not be activated in adult mice. The identities of 
those compensatory mechanisms still remain to be elucidated. 
 
α4β1 and α5β1 integrins 
 
 The functions of α5β1 integrin on proplatelet formation are documented inhuman 
megakaryoblastic CHRF-288 cell line. Phorbol 12-myristate 13-acetate (PMA) and 
fibronectin co-stimulation induced CHRF-288 cells to undergo megakaryocytic 
differentiation, maturation, and proplatelet formation whereas stimulation with other ECM 
ligands such as collagen, vitronectin, and laminin showed minimal proplatelet formation. 
 
20 
Fibronectin adhesion, together with PMA induced activation of protein kinase C (PKC) 
pathway is proved to be essential for proplatelet formation in CHRF-288 cells (Jiang, Jia 
et al. 2002). The identity of integrins binding to fibronectin in CHRF-288 cells was 
confirmed in another study where anti-α4 plus anti-α5 antibodies were found to abrogate 
proplatelet formation whereas anti-α4 or anti-α5 antibody alone did not inhibit proplatelet 
formation suggesting (Matsunaga, Fukai et al. 2012). 
However, it is important to note that the expressional profile of integrins on MKs and 
CHRF-288 cells are different as α4β1 integrin is hardly expressed on mature MKs. Whether 
MKs proplatelet formation can be stimulated by α5β1 integrin alone and whether MKs 




αIIbβ3 binding to fibrinogen has been proved to stimulate proplatelet formation. 
Murine MKs plated on fibrinogen showed the greatest proportion of proplatelet formation 
compared to MKs plated on laminin, vitronectin, vWF, and collagen, and lotrafiban, an 
αIIbβ3 integrin antagonist, abolished proplatelet formation on fibrinogen (Larson and 
Watson 2006). As previously introduced, αIIbβ3 integrin activates downstream SFKs (Src 
Family Kinase)-Syk-PLCγ2 signaling (Mazharian, Thomas et al. 2010). This signaling 
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pathway, although having a positive effect on MK spreading and migration, seems to 
negatively regulate proplatelet formation as Larson et al. also showed that a Src family 
kinase inhibitor resulted in a significant increase in the percentage of megakaryocytes with 
proplatelets (Larson and Watson 2006). 
 The signaling cascade involving αIIbβ3 integrin induced proplatelet-like structure has 
been proved to be conserved across different cell types. Mutant versions of αIIbβ3 integrin, 
αIIbβ3D723H and αIIbβ3D723A, that are partially active and can spontaneously bind 
fibrinogen, were expressed in Chinese Hamster Ovary (CHO) cells. CHO cells formed 
cytoplasmic protrusions after adhesion to fibrinogen, mimicking proplatelets, and the 
elongation of the protrusions was proved to be microtubule-driven since nocodazole, a 
microtubule polymerization inhibitor, totally prevented the development of those 
cytoplasmic extensions (Schaffner-Reckinger, Salsmann et al. 2009). Interesting to note, 
small Rho GTPase RhoA activity was strongly inhibited in partially activated 
αIIbβ3D723H and αIIbβ3D723A cells (but not in wildtype αIIbβ3 cells or fully activated 
αIIbβ3 cells), reminiscent of the previous discussion that Rho/ROCK signaling cascade 
induced by α2β1 integrin binding to collagen led to stress fiber formation but inhibited 
proplatelet formation in human MKs (Sabri, Jandrot-Perrus et al. 2004). Taken together, 
these findings suggest integrin-dependent Rho/ROCK pathway play essential roles 
regulating the formation of proplatelet-like structure, and different integrins and their 
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activation states may have differential effects on Rho/Rock pathway activation. 
The identification of filamin A (FLNa), a mediator in the αIIbβ3 dependent Rho/ROCK 
pathway further elucidates the regulatory control on proplatelet formation. After adhesion 
of αIIbβ3 to fibrinogen, FLNa is proved to connect cytoplasmic tail of αIIbβ3 to RhoA, 
keeping RhoA in a GDP -bound inactivated state. Inactivated RhoA inhibits downstream 
ROCK protein, and the inhibition stimulates proplatelet formation. However, the absence 
of FLNa results in RhoA in an GTP-bound activated state, which in turn activates 
downstream ROCK protein causing defective actomyosin contractility and proplatelet 
formation (Donada, Balayn et al. 2019).  
The mutation effect of αIIbβ3 integrin has also been studied extensively on patients 
with congenital defects. Mutations associated with disruption of the αIIb R995/β3 D723 
salt bridge, αIIbR995W, and previously described β3D723H, have been proved to 
negatively affect proplatelet formation in human patients. These two mutations are 
considered to result in a constitutively active conformation of αIIbβ3 integrin resulting in 
aberrant outside-in signaling (Kashiwagi, Kunishima et al. 2013). In those patients, 
proplatelet numbers tended to be lower and appeared to be swollen with decreased 
branching, and the tips of proplatelets tended to be larger compared to control MKs, 
consistent with low platelet counts and enlarged platelets also reported in those patients 
(Favier, Bordet et al. 2018). The murine model was also studied by introducing αIIbR990W 
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mutation in mice, which corresponds to R995W in human αIIb. Although there were no 
significant differences in the number of megakaryocytes and ploidy of MKs, proplatelet 
formation was significantly impaired in αIIbR990W mice, resulting in reduced platelet 
count (Akuta, Kiyomizu et al. 2020). Taken together, these results suggest that regulation 
of αIIbβ3 activation state, although may not affect megakaryopoiesis and MK maturation, 




The effect of α6β1 integrin on proplatelet formation is poorly documented. Murine MKs 
plated on laminin were reported to have a moderate amount of proplatelet formation, which, 
albeit much less than fibrinogen, were greater than other ECM ligands such as vitronectin, 
collagen, and vWF (Larson and Watson 2006), suggesting α6β1 signaling may serve as 
complementary but inefficient control on proplatelet formation. Further research is 





INTEGRIN DEPENDENT INTERACTIONS BETWEEN MK AND OTHER 
CELLS 
 
MKs interact with osteoblasts 
 
MK to osteoblast interaction was first characterized in mice deficient in GATA-1 or 
NF-E2, two essential transcriptional factors for MK differentiation. Those mice were 
observed with elevated osteoblast number and highly increased bone formation. Further in 
vitro experiments demonstrate that mutant MKs as well as wild MKs strongly enhanced 
osteoblast proliferation through direct cell contact, suggesting that the increased numbers 
of MKs in mutant mice BM due to GATA-1 or NF-E2 defects may be responsible for the 
excessive bone formation in those mice (Kacena, Shivdasani et al. 2004). MK induced 
osteoblast proliferation was also observed in mice treated with total body irradiation. 
Surviving MKs were observed migrating toward the endosteal surface of trabecular bone 
from their normal para-sinusoidal site and inducing a twofold expansion of osteoblasts 
(Dominici, Rasini et al. 2009). 
Further studies have revealed the role of MK integrins and their signaling pathway in 
regulating osteoblast proliferation. Lemieux et al. showed that EDTA and tetrapeptide 
RGDS treatment to an in vitro co-culture of MKs and osteoblasts diminished MK induced 
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osteoblast proliferation, strongly suggesting the involvement of RGD-binding integrins 
(Lemieux, Horowitz et al. 2010). Neutralizing antibodies against RGD-binding integrins 
(α3β1, α5β1, and αIIbβ3 integrins) were applied to test their respective effect, and the result 
showed that all antibodies had an inhibitory effect on osteoblast proliferation, suggesting 
all fibronectin-binding integrins on MKs played a role in osteoblast proliferation (Lemieux, 
Horowitz et al. 2010). 
The integrin-dependent proliferation of osteoblasts has been suggested to be mediated 
by proline-rich tyrosine kinase 2 (Pyk2). Pyk2 level in osteoblasts was elevated when co-
cultured with MKs, and Pyk2 inhibited downstream p53-Mdm2 pathway, resulting 
osteoblasts to be more permissive of cell cycle entry (Cheng, Hooker et al. 2013). Since 
Pyk2 is known to be activated after integrin engagement in other cell types (Avraham, Park 
et al. 2000), it is likely to be an essential mediator in MK induced osteoblast proliferation. 
However, the identities of cell surface receptors on osteoblasts to which MKs adhere via 
integrins remain to be unclear. Signaling cascades in osteoblasts triggered by adhesion of 
integrins and differential roles of different MK integrins still require to be elucidated. 
 
MKs interact with fibroblasts 
 
 Primary Myelofibrosis (PMF) is considered to be resulted by the deregulation of MK 
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induced fibroblast proliferation and secretion, leading to excessive accumulation of ECM 
fibers in the BM (Malara, Abbonante et al. 2018). Platelet derived growth factor (PDGH), 
and transforming growth factor β1 (TGF-β1) secreted by MKs are proved to play essential 
roles in stimulating proliferation of fibroblasts as well as secretion of matrix products such 
as collagen and fibronectin (Kimura, Katoh et al. 1988, Kimura, Katoh et al. 1989). 
However, direct contact between MKs and fibroblasts has been proved to be necessary for 
stimulation. Tissue culture inserts were employed to inhibit direct cell contact in human 
MK-fibroblast co-culture, and the result showed a significant impairment of fibroblast 
proliferation (Schmitz, Thiele et al. 1995), suggesting direct cell contact assisted in 
achieving a local concentration threshold of PDGF and TGF-β1 required for fibroblast 
stimulation. 
 Since direct cell contact was required for fibroblast stimulation, further studies were 
undertaken to examine the roles of MK integrins in fibroblast stimulation. Fibroblast 
growth was significantly impaired with the addition of anti-α3 and anti-α5 antibodies to 
the human MK-fibroblast co-culture, and the adhesion of MKs to fibroblasts was also 
reduced. On the other hand, anti-α2 and anti-α6 antibodies did not cause significant 
decrease in adhesion and fibroblast growth, suggesting adhesion to fibroblasts was 
mediated by fibronectin-binding α3β1 and α5β1 integrins (Schmitz, Thiele et al. 1998). 
Another study investigating the function of αIIbβ3 on fibroblast stimulation showed anti-
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αIIb antibody resulted in reduced fibroblast growth but not reduced adhesion to fibroblasts. 
In addition, other cell adhesion molecules such as selectins were reported to facilitate MK 
attachment to fibroblasts and thereby stimulating fibroblast growth (Wickenhauser, 
Schmitz et al. 2000).  
 Taken together, stimulation of fibroblasts by MK integrins involve different mechanisms. 
α3β1 and α5β1 integrin seem to stimulate fibroblast growth by facilitate cell adhesion, 
thereby increasing local concentration for PDGF, TGF-β1, and other growth factors to 
stimulate fibroblast growth. On the other hand, αIIbβ3 integrin may trigger a specific 
signaling cascade in fibroblasts, which stimulate growth. However, the presence of this 
proposed signaling pathway remain to be verified, and the regulatory functions of MK 





DISEASES RELATED TO MK INTEGRINS 
 
Glanzmann’s thrombasthenia (GT) 
 
GT is an autosomal recessive bleeding disorder associated with mutations in αIIbβ3 
integrin, classically characterized by prolonged bleeding time and failure of platelets to 
binding fibrinogen and aggregate in response to ADP, collagen, thrombin and epinephrine 
(Seligsohn 2002). In rare cases, GT can also present as an acquired autoimmune disorder 
caused by an autoantibody targeting αIIbβ3 integrin (Tholouli, Hay et al. 2004). Although 
platelet count is usually normal for GT patients, certain mutations in some cases can cause 
impaired platelet production and function, leading to macrothrombocytopenia 
characterized by low platelet counts with enlarged platelet volume (Nurden, Pillois et al. 
2011, Bury, Malara et al. 2012, Kashiwagi, Kunishima et al. 2013). Those cases have been 
suggested to involve proplatelet formation in MKs. 
As previous discussed, MKs of patients with mutations associated with αIIb R995/β3 
D723 salt bridge exhibited defective proplatelet formation, leading to 
macrothrombocytopenia and GT like syndromes (Favier, Bordet et al. 2018). Similar 
findings were reported in another study where a β3 subunit deletion (del647-686) also led 
to macrothrombocytopenia resulted by lowered proplatelet number and enlarged 
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proplatelet tips (Bury, Malara et al. 2012). Additional mutations associated with αIIbβ3 
integrins were reported in patients with congenital macrothrombocytopenia, including αIIb 
Gly991Cys, αIIb Phe993del, and β3 (del621-660) (Kashiwagi, Kunishima et al. 2013). All 
these mutations discussed above were reported to result in constitutively active αIIbβ3 
integrins and reduced αIIbβ3 expression on surface of MKs and platelets, suggesting the 
regulation of αIIbβ3 activation play central roles in proplatelet formation and morphology. 
Enlarged platelets may be the result of deformed proplatelets, and impaired platelet 
function may be due to reduced surface expression of αIIbβ3 integrin. 
 
Primary Myelofibrosis (PMF) 
 
 PMF is characterized by excessive accumulation of ECM in the BM and BM fibrosis, 
and pathology of PMF has been proved to involve MK hyperplasia and BM stromal cell 
stimulation (Malara, Abbonante et al. 2018). Increased number of MKs in PMF patients 
results in a high level release of TGF-β1 and PDGF, which signal BM fibroblasts to 
proliferate and overproduce collagen, leading to increased stiffness of the ECM (Kimura, 
Katoh et al. 1988, Kimura, Katoh et al. 1989). MKs in PMF patients also have abnormal 
expression and secretion of several cytokines and chemokines, and the abnormal levels of 
those factors disrupt the BM microenvironment and cause fibrosis (Leiva, Ng et al. 2017). 
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The role of MK integrins in PMF has been recently studied in a transgenic mouse 
model (JAK2V617F). MKs in those mice had increased cell surface expression of α5β1 
integrin and enhanced adhesion to fibronectin, and neutralizing antibody to the α5 subunit 
lowered adhesion to fibronectin and reduced the number of MKs in vivo (Matsuura, 
Thompson et al. 2020).Taken together with the fact that fibronectin content is elevated in 
BM of JAK2V617F mice (Matsuura, Thompson et al. 2020), these finding suggest a 
positive feedback in which MK proliferation is stimulated by high levels of α5β1 integrin 
as well as BM fibronectin, and MK proliferation in turn stimulates fibroblast to secret more 
fibronectin, which leads to more severe megakaryocytosis. 
 
Immune thrombocytopenic purpura (ITP)  
 
 ITP is an autoimmune disease resulted by platelet autoantibodies which stimulate platelet 
destruction and inhibit platelet production; however, the cause of platelet autoantibodies 
formation is still largely unknown (Cines, Bussel et al. 2009). Autoantibodies against MK 
integrins such as αIIbβ3 and αvβ3 were detected on chronic ITP patients (Najaoui, 
Bakchoul et al. 2012, Zeng, Chen et al. 2018). 
 Both anti‐αIIbβ3 and anti-αvβ3 autoantibodies resulted in low platelet count, and the 
effect seemed to be addictive as evidenced by patients with both autoantibodies having the 
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lowest platelet count (Zeng, Chen et al. 2018). As previously discussed, although anti-αvβ3 
antibody had no significant effect on the survival and proliferation of human MKs, it 
resulted in impaired proplatelet formation and MK migration toward sinusoids (Zeng, Chen 
et al. 2018). Taken together, impaired proplatelet formation and MK migration may 






  MK integrins has been proved to play vital roles in MK differentiation, MK maturation, 
and thrombopoiesis, and their interactions with other cells in the BM are regulated 
intricately to maintain homeostasis, and deregulation and malfunction of MK integrins can 
lead to systemic diseases. Although the extracellular ligands have been identified for 
integrins, the intracellular signaling cascade triggered by ligand binding remain to be 
elucidated. For example, as previously discussed, both α2β1 and αIIbβ3 are associated with 
downstream Rho/Rock pathway, but having differential effects on MK functions, which 
suggests the presence of intermediate factors able to recognize different integrins and exert 
different regulatory control. However, the identities of those intermediate factors and the 
mechanisms of interactions are still largely unknown. In addition, recent studies suggest 
integrins are responsive to mechanical signals such as the stiffness of ECM ligands. This 
finding may provide some insights to integrin signaling. Since different ECM ligands have 
varied stiffness, adhesion of ECM ligands to their respective integrins may transmit 
distinctive mechanical signals dictating differential cell response. MK response to 
mechanical signals via integrins is still a relatively new topic and not very well documented. 
Further research is required in the future to elucidate the integrin signaling pathway in MKs 
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